A recent study of U.S. Veterans Affairs hospitals highlights the challenges of diagnostic discordance and uncertainty in community-acquired pneumonia (CAP). With over half of patients experiencing conflicting diagnoses from initial presentation to discharge, the need for improved diagnostic tools is clear. https://lnkd.in/dKzuHSRf Diagnostic tools such as #MeMedBV can assist in reducing uncertainty by providing rapid and accurate differentiation between #bacterial and #viral infections. This ability has the potential to enhance clinical decision-making, reduce unnecessary treatments, and ultimately improve patient outcomes. As we continue to push the boundaries of healthcare innovation, it's crucial to adopt tools that not only address diagnostic challenges but also improve antibiotic stewardship. https://lnkd.in/dRQ-yQz5 #HealthcareInnovation #AntibioticStewardship #MeMedBV
MeMed
Biotechnology Research
Haifa, Israel 15,268 followers
Decoding the Host Immune Response to Generate Insights that Improve Lives.
About us
MeMed is a leading med tech and bio-convergence company, having developed innovative diagnostic host immune response testing methods that address complex clinical dilemmas and improve patient outcomes. Our mission is to translate the complex signals of the immune system into simple diagnostic insights that transform the way we treat infectious diseases and inflammatory disorders – at the right place and the right time.
- Website
-
https://www.me-med.com/
External link for MeMed
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Haifa, Israel
- Type
- Privately Held
- Specialties
- host immune response testing, personalized diagnostics, antimicrobial resistance, systems immunology, point-of-care, IVD, med tech company, bio-convergence company, machine learning, and infectious disease testing
Locations
-
Primary
7 Nahum Heth st. Park High-Tech North
Haifa, Israel 3508506, IL
-
200 Brickstone Sq
Suite 106
Andover, Massachusetts 01810, US
Employees at MeMed
Updates
-
Experts predict that by 2050, antibiotic resistance could kill 10 million people annually. Big pharma isn't interested, startups can't survive on this issue alone, and government funding is dwindling. But beneath the surface, a new reality is taking shape. This may sound like science fiction, but it's closer to reality than you think. 1.27 million people already die from antibiotic-resistant infections each year. "It's like a frog in a boiling pot," says Eran Eden Memed co-founder and CEO, "We don't notice the gradual change." Read the full (Hebrew) Globes story here> https://lnkd.in/dtWM-9M9 #antibioticresistance
למעלה ממיליון איש כבר מתים בשנה מהאיום הזה
globes.co.il
-
Exciting updates from Texas! 🌟📍 Since launching MeMed BV in #microhospitals and #freestandingemergencydepartments across Texas, the feedback has been overwhelmingly positive. Our mission to enhance clinical accuracy and patient satisfaction is resonating deeply within these communities. 📊 Impactful Results: Facilities implementing MeMed BV are seeing a marked improvement in diagnostic precision and treatment efficacy. This not only boosts patient outcomes but also streamlines clinical workflows. 🔗 Strong Partnerships: We are thrilled to announce new partnerships with several micro-hospitals, expanding our reach and impact. Together, we are setting new standards in emergency medicine diagnostics. 🌍 Community Engagement: Our team has been actively participating in local healthcare events and workshops, fostering a community of innovation and learning. 💡 Continuous Innovation: At MeMed, we are committed to continuous improvement. Stay tuned for upcoming enhancements to MeMed BV, designed to further support our healthcare providers and their patients. Thank you to all our partners and customers in Texas for your trust and collaboration. We are excited to keep pushing the boundaries of what's possible in healthcare diagnostics together! #HealthcareInnovation #MeMedBV #PatientSatisfaction #TexasFSED #HealthcareTechnology
MeMed BV® | Distinguishing Bacterial from Viral Infections | MeMed
http://www.me-med.com
-
In a world where everything from classes to groceries is becoming more virtual, medicine is following suit. While virtual care offers many conveniences, it also brings new challenges—particularly in the rise of prescribed antibiotics. A recent study highlights a notable difference: 58% of virtual urgent care visits resulted in an antibiotic prescription compared to 43% of in-person visits. Interestingly, sinusitis diagnoses were more than twice as common in virtual care, contributing to this trend. This finding underscores the need to closely monitor and evaluate antibiotic prescribing practices in the expanding realm of virtual healthcare. #Antibioticstewardship is crucial and must be approached with care to prevent overuse and ensure long-term efficacy. https://lnkd.in/dHcF2F9g #HealthcareInnovation #MeMedBV #Diagnostictool
Antibiotic prescribing for respiratory tract infections in urgent care: a comparison of in-person and virtual settings
academic.oup.com
-
We're #hiring a new Head of Regulatory Affairs and Quality Assurance (RA/QA) in Haifa District. Apply today or share this post with your network.
-
🔬 Navigating Pediatric Care: The Crucial Role of Antibiotic Stewardship As parents, our instinct is to do whatever it takes to make our children feel better—fast. This often leads us to seek immediate solutions like antibiotics. Yet, the frequent use of antibiotics for mild respiratory symptoms highlights the need for a careful evaluation of their necessity and effectiveness. Finding harmony between clinical guidelines and parental expectations is essential. By prioritizing education, embracing technological advances, and committing to antibiotic stewardship, we can safeguard the efficacy of these vital treatments for future generations. 👇 Dive into our latest blog post to learn more. https://lnkd.in/dtZBVz6i #PediatricCare #AntibioticStewardship #HealthcareInnovation #MeMed
Tiny Patients, Big Decisions: The Delicate Balance of Antibiotics in Pediatric Care | MeMed
http://www.me-med.com
-
We're #hiring a new Clinical Account Manager in Texas. Apply today or share this post with your network.
-
🌟Don't miss Tanya Gottlieb's insightful presentation today at 2:35 PM at FederalAB, where she'll be discussing the implementation and appropriate use of #MeMedBV, the groundbreaking tool for distinguishing between #bacterial and #viral infections. This session is a must-attend for anyone interested in the cutting-edge of medical diagnostics. See you there! https://lnkd.in/gfPWrDt #HealthcareInnovation #MedicalDiagnostics #MeMed
16th Annual Next Generation Dx Summit | August 19-21, 2024 | Washington, D.C. + virtual
nextgenerationdx.com
-
We are thrilled to announce our new partnership with AB Scientific, a distinguished player in the UK diagnostic market. This collaboration marks a significant milestone in our mission to revolutionize sepsis diagnostics and combat antimicrobial resistance globally. Aaron Eglin, Rapid Diagnostics Sales Manager at AB Scientific, shares: "We believe that the MeMed BV test can improve sepsis diagnostics here in the UK and also reduce the burden of antimicrobial resistance by reducing the number of inappropriate treatments provided unnecessarily to patients." Together, we are set to make a substantial impact on patient care and public health in the UK. We look forward to a fruitful collaboration with AB Scientific, driving innovation and delivering cutting-edge solutions to the healthcare challenges of today. https://lnkd.in/d8XeQ_Ap #MeMed #ABScientific #HealthcareInnovation #SepsisAwareness #AntimicrobialResistance #DiagnosticSolutions #UKHealthcare #Partnership
Press Release: MeMed - AB Scientific
https://www.abscientific.com
-
❔MeMed BV #FAQs How do you interpret BV results ❔ The MeMed BV® test result is a score between 0 and 100 derived from computational integration of the measurements of the three proteins TRAIL, IP-10, and CRP. Low scores are indicative of a viral infection, and high scores suggest a bacterial infection. Most MeMed BV results fall at the two extremes of the score spectrum, either between 0-10 or 90-100. Learn more: www.me-med.com/memed-bv #MeMedBV #HealthTech #DiagnosticTechnology #BacterialVsViral #InnovationInHealthcare
-